Janux Therapeutics, Inc. (JANX) Misses Q2 EPS by 8c

Janux Therapeutics, Inc. (NASDAQ: JANX) reported Q2 EPS of ($0.35), $0.08 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $10.27 million versus the consensus estimate of $17.94 million.

For earnings history and earnings-related data on Janux Therapeutics, Inc. (JANX) click here.

You May Also Be Interested In

• Movano (MOVE) Misses Q2 EPS by 195c
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c